Soliris (eculizumab) 300 mg/30 mL concentrate for solution for infusion (Alexion) Indications for the use of the drug Soliris are: paroxysmal nocturnal hemoglobinuria.

Price upon request

Indications for use

Indications for the use of Soliris are: paroxysmal nocturnal hemoglobinuria.
The effectiveness of Soliris has been confirmed only in patients with PNH who have previously received transfusions of blood or its components.

Method of administration

Soliris is administered intravenously by drip over 25-45 minutes.
The course of treatment includes a 5-week initial cycle followed by a maintenance cycle.
Initial cycle: 600 mg of Soliris once a week for 4 weeks, on the 5th week - 900 mg once a week.
Maintenance phase: 900 mg of Soliris is prescribed every 14±2 days.